Equity
€248,337 ▼ 39.7%
DR. G. HOLLANDERS paid out €250,405 in dividends. That is 288% of the 2025 profit.
DR. G. HOLLANDERS
Lifetime
20 annual accounts with figures on one time axis, 30 filings since 1996peak €303,195 (2018)
€99,449▼ 54.1%
lowest -€6,857 (2023)
€86,828▼ 10.5%
peak €588,197 (2009)
€248,337▼ 39.7%
€356,355▲ 4.4%
peak 1.2 FTE (2008)
-not published
Board2 names since 2013
1 director
Documentsfilings and deeds
31-07-2026on the last day
2025micro format
Gross margin from €216,581 to €99,449Dividend €250,405Equity from €411,914 to €248,337
Key points
from the 2025 annual accountsInvestments
€21,378 3.2 × depreciation
Green is investment, beige is depreciation.
Filings
30 annual accounts since 1996
Eight of the last ten came late. The 2022 accounts came latest: 436 days after the end of the period.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 20,135 companies had the same profile as DR. G. HOLLANDERS has now. Each dot stands for 51 companies, two years later.
95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,135 companies, not a prediction for DR. G. HOLLANDERS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Change of role: , from manager to director
“De uitoefening van de geneeskunde met specialisatie interne-geneeskunde of aanverwante discipline door de…” (deed in Dutch) · General meeting of 16-11-2022 · Gazette deed
Merger: DR. G. HOLLANDERS takes over
Resignation: (manager) · “Het door de vennoten, met uitsluiting van de vennootschap zelf, in vennootschapsverband beoefenen van de…” (deed in Dutch) · The company holds all the shares of · Gazette deed
Merger proposal: DR.G.HOLLANDERS takes over
holds all the shares · The company holds all the shares of · Gazette deed
Capital increase · Amendment of the articles
Capital from €85,110 to €18,600 · Capital from €18,600 to €85,110 · General meeting of 25-12-2017 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. G. HOLLANDERS Nazareth-De Pinte | €604,693 | €99,449 | 41.1% | - |
| Dokter Marc BACKAERT Ostend | €561,822 | €97,707 | 94.3% | - |
| ORTHODES Péruwelz | €618,350 | €94,535 | 81.2% | - |
| Dokter I. Van Looveren Antwerp | €558,059 | €109,034 | 98.9% | - |
| CABINET MEDICAL DU DOCTEUR BRICTEUX Liège | €573,191 | €110,612 | 39.4% | - |
| DEMETER Uccle | €689,959 | €99,933 | 95.0% | - |
| DOKTER KATTY BOURGOIGNIE Ostend | €710,655 | €97,247 | 97.8% | - |
These companies have the same main activity as DR. G. HOLLANDERS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €558,000 and €711,000, founded between 1992 and 1998.
Official details
Source: KBO- Status
- Active since 22-02-1995Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Financial year end
- 31 December
- Peppol
- Reachable
Annual accounts 2025
- ≈ €220,000estimated
- €604,693▼ 19.7%
- Filing
- Filed on 31-07-2026, on the last day of the filing period
Insights on DR. G. HOLLANDERS
DR. G. HOLLANDERS files the micro format. That format states no turnover. The gross margin fell from €294,509 in 2006 to €99,449 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. G. HOLLANDERS
- What is the company number of DR. G. HOLLANDERS?
- The company number of DR. G. HOLLANDERS is 0454.629.793. The VAT number is the same number with BE in front: BE 0454.629.793.
- Where is DR. G. HOLLANDERS based?
- The registered office is at Magaret 5, 9840 Nazareth-De Pinte.Company details
- What does DR. G. HOLLANDERS do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR. G. HOLLANDERS?
- DR. G. HOLLANDERS is a private limited company (BV).
- When was DR. G. HOLLANDERS founded?
- DR. G. HOLLANDERS was founded on 22-02-1995.
- Is DR. G. HOLLANDERS still active?
- Yes, DR. G. HOLLANDERS is an active enterprise in the KBO register.
- How many employees does DR. G. HOLLANDERS have?
- DR. G. HOLLANDERS had an average of 0.8 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
- What is the turnover of DR. G. HOLLANDERS?
- The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €99,449 and 32 comparable companies (NACE 862). It probably lies between €170,000 and €290,000.
- Is DR. G. HOLLANDERS profitable?
- In financial year 2025, DR. G. HOLLANDERS made a profit of €86,828.
- Where can I find the annual accounts of DR. G. HOLLANDERS?
- DR. G. HOLLANDERS filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. G. HOLLANDERS due?
- DR. G. HOLLANDERS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.